Finding the best dose to reduce blood loss in major back surgery
NCT ID NCT07288697
Summary
This study tested two different doses of a medication called tranexamic acid (TXA) to see which works better at controlling bleeding during major spinal fusion surgery. It involved 62 adults having surgery on three or more vertebrae in their mid-to-lower back. Researchers measured how much blood patients lost during surgery and whether they needed a blood transfusion, aiming to find the safest and most effective dose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEGENERATIVE SPINE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kartal Dr. Lütfi Kırdar Şehir Hastanesi
Istanbul, 34865, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.